JP Morgan Chase
IMMU

JP Morgan Chase’s Immunomedics Inc IMMU Stock Holding History

JP Morgan Chase’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-15,700
Closed -$224K – 6166
2018
Q4 		$224K Sell
15,700
-34,300
-69% -$681K ﹤0.01% 4544
2018
Q3 		$1.04M Buy
+50,000
New +$1.18M ﹤0.01% 3888

JP Morgan Chase's IMMU Position: Q4 2020 in Review

JP Morgan Chase sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,135,108 shares — an estimated $96.8M sold.

JP Morgan Chase first reported a position in IMMU in Q2 2013 and held it in 17 quarters. The position peaked at $96.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • JP Morgan Chase reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • JP Morgan Chase sold 1,135,108 Immunomedics Inc shares in Q4 2020, an estimated $96.8M.
  • JP Morgan Chase first reported a position in Immunomedics Inc in Q2 2013 and held it in 17 quarters.
  • JP Morgan Chase's Immunomedics Inc position peaked at $96.8M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.